Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of product candidates derived from its lipid-crystal nano-particle, or cochleate, delivery technology platform. The firm's pipeline includes MAT2203, MAT2501 and others.
This is not a financial advice!
Be carful before entering Monday is ER coming.
Upcoming catalyst in 2H 2024
Block buy recently
Rel. Vol. on 03/15/2024 at 3.9
We need to stay in a bullish overal sentiment of the market. If we see a corretion, this play might doesn't work.
Keep an eye on 0.85/ 1.0 levels, needs to get broken for a further upmove. You can take partial profits at these levels if u want to lock in gains.
SL under 0.15
TP approx. 1.5
Most info on the chart.
Trade carefully!